Showing results (1211-1220 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|March 20, 2020
Economic burden of patients with advanced non-small-cell lung cancer receiving nivolumab versus chemotherapy in ChinaQingqing Chai, Yunjie Shen, Jiangyang Du, et al.
Immunotherapy|January 24, 2020
The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance studyEnrico Compalati, Cristoforo Incorvaia, Sara Urbano, et al.
Immunotherapy|January 30, 2020
Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case reportCole Billena, Shilpa Padia, Bridget O'Brien, et al.
Immunotherapy|September 5, 2014
Cancer CARtography: charting out a new approach to cancer immunotherapyJaina M Patel, Gordon A Dale, Vincent F Vartabedian, et al.
Immunotherapy|September 5, 2014
Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysisZheng-Xu Wang, Jun-Li Li, Jun-Xia Cao, et al.
Immunotherapy|November 10, 2020
Ixekizumab in the treatment of psoriatic arthritisEric Lespessailles, Hechmi Toumi
Immunotherapy|November 5, 2020
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studiesMelania Rivano, Luca Cancanelli, Lorenzo Di Spazio, et al.
Immunotherapy|November 11, 2020
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findingsHorst-Dieter Hummel, Peter Kufer, Carsten Grüllich, et al.
Immunotherapy|July 27, 2022
Late-onset toxicities of monoclonal antibodies in cancer patientsMai Alalawi, Abrar Saeed Bakr, Rowaida Reda, et al.
Immunotherapy|July 27, 2022
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasmaMikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, et al.
Pageof 188